Clinical course and mortality risk of severe COVID-19
- 17 March 2020
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 395 (10229), 1014-1015
- https://doi.org/10.1016/s0140-6736(20)30633-4
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational studyThe Lancet Respiratory Medicine, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Sequential organ failure assessment score is an excellent operationalization of disease severity of adult patients with hospitalized community acquired pneumonia – results from the prospective observational PROGRESS studyCritical Care, 2019
- Viral Load Kinetics of MERS Coronavirus InfectionThe New England Journal of Medicine, 2016
- Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus InfectionClinical Infectious Diseases, 2015
- D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trialEuropean Journal of Internal Medicine, 2012
- Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndromeThe Lancet, 2004